155 related articles for article (PubMed ID: 30674935)
21. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
22. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
23. The Association between Vascular Endothelial Growth Factor-related Factors with Severity of Multiple Sclerosis.
Kouchaki E; Otroshi Shahreza B; Faraji S; Nikoueinejad H; Sehat M
Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):204-11. PubMed ID: 27424135
[TBL] [Abstract][Full Text] [Related]
24. A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.
Pesson M; Eymin B; De La Grange P; Simon B; Corcos L
Mol Cancer; 2014 Jan; 13():9. PubMed ID: 24428911
[TBL] [Abstract][Full Text] [Related]
25. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
[TBL] [Abstract][Full Text] [Related]
26. Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis.
Wang Z; Liu T
Mol Cell Biochem; 2018 Feb; 439(1-2):163-169. PubMed ID: 28861767
[TBL] [Abstract][Full Text] [Related]
27. SOX2 modulates alternative splicing in transitional cell carcinoma.
Tung CL; Hou PH; Kao YL; Huang YW; Shen CC; Cheng YH; Wu SF; Lee MS; Li C
Biochem Biophys Res Commun; 2010 Mar; 393(3):420-5. PubMed ID: 20138825
[TBL] [Abstract][Full Text] [Related]
28. Reduction in the mRNA expression of sVEGFR1 and sVEGFR2 is associated with the selection of dominant follicle in cows.
Ortega Serrano PV; Guzmán A; Hernández-Coronado CG; Castillo-Juárez H; Rosales-Torres AM
Reprod Domest Anim; 2016 Dec; 51(6):985-991. PubMed ID: 27650571
[TBL] [Abstract][Full Text] [Related]
29. Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.
Abou-Fayçal C; Hatat AS; Gazzeri S; Eymin B
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208660
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
32. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
34. Danggui Buxue decoction promotes angiogenesis by up-regulation of VEGFR
Hu G; Yang P; Zeng Y; Zhang S; Song J
J Chin Med Assoc; 2018 Jan; 81(1):37-46. PubMed ID: 28882731
[TBL] [Abstract][Full Text] [Related]
35. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.
Wu FT; Stefanini MO; Mac Gabhann F; Kontos CD; Annex BH; Popel AS
J Cell Mol Med; 2010 Mar; 14(3):528-52. PubMed ID: 19840194
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway.
Liu W; Xu J; Wang M; Wang Q; Bi Y; Han M
Int J Oncol; 2011 Nov; 39(5):1213-20. PubMed ID: 21785819
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
38. VEGFR1(D2) in drug discovery: Expression and molecular characterization.
Di Stasi R; Diana D; Capasso D; Palumbo R; Romanelli A; Pedone C; Fattorusso R; D'Andrea LD
Biopolymers; 2010; 94(6):800-9. PubMed ID: 20564033
[TBL] [Abstract][Full Text] [Related]
39. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
40. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
